Overview

Study of the Way the Body Takes up, Distributes, and Gets Rid of ACT-541468 in Subjects With Abnormal Kidney Function Compared to Healthy Subjects

Status:
Completed

Trial end date:
2020-08-14

Target enrollment:

Participant gender:

Summary

Study of the way the body takes up, distributes, and gets rid of ACT-541468 in subjects with abnormal kidney function compared to healthy subjects

Phase:

Phase 1

Details

Lead Sponsor:

Idorsia Pharmaceuticals Ltd.